Micha Abeles is a dedicated rheumatologist currently serving the Meriden area of Connecticut.

 

He is a highly experienced medical professional, board certified in both rheumatology and internal medicine for over four decades. Throughout his more than 40 years of practice, Micha has garnered much recognition and praise, not only in his community but nationwide for his extensive list of groundbreaking research papers and discoveries.

Micha has been a respected mentor to doctors nationwide and continues to share his experience and expertise 40 years later. During his years as a professor of medicine at the University of Connecticut Health Center, Micha Abeles established quite the reputation as an innovative researcher. Throughout his near four decades of practice, Micha oversaw numerous clinical trials leading to the development of Humira and Enbrel, which are two significant arthritis medications that are still in use today.

Amongst his research, Micha Abeles demonstrated the effectiveness of phosphodiesterase type 5 inhibitors in treating Buerger disease and methotrexate in treating rheumatoid arthritis. During this time, Micha was able to conduct original research — which ultimately lead the way to being a co-author of a 1990 fibromyalgia criteria paper, which was the first study that fully defined the syndrome. Not only that, but Micha, along with his co-investigators, were among the first researchers to associate the use of steroids and avascular necrosis, which is the death of bone tissue due to a lack of blood supply.

In addition, Micha spearheaded numerous research studies about arthritis. A few notable published articles include “Aseptic necrosis in systemic lupus erythematosus: Relationship to corticosteroid therapy” and “Eosinophilic fasciitis – A clinical pathological correlation,” both of which were published in The National Center for Biotechnology Information’s (NCBI) Archives of Internal Medicine in the late 1970s. Micha Abeles also published “Acute gouty arthritis: The diagnostic importance of aspirating more than one involved joint” in The Journal of the American Medical Association (JAMA) in the late 1970s as well.

Micha Abeles’ career in rheumatology only began in 1976, after leaving the U.S. Army. During his time in the force, he served as a major and chief of the outpatient department at Fort Monroe VA, from 1974-1976. Over the course of those two years, Micha Abeles received much recognition and praise for his outstanding clinical skills and his ability to boost morale in the unit. After leaving the force, he took a fellowship in rheumatology at the University of Connecticut where he continued to serve in numerous capacities throughout his lifelong career in rheumatology.

Over the course of his career, Micha Abeles also studied Lyme disease; myositis, which is the inflammation of the muscles; vasculitis, which is inflammation of the blood vessels; and polymyalgia rheumatica, which is muscle pain and stiffness around the shoulders and hips.

Micha Abeles’ skills and discoveries are undoubtedly unparalleled. His unprecedented work as a medical professional has been rightfully acknowledged nationwide. He has been voted Top Doctor in Connecticut for over two decades now, in addition to being listed as Best Doctor and Castle Connolly Top Doctor, a highly regarded medica source for consumers, for several years.

Today, Micha Abeles practices both rheumatology and internal medicine with his son at his private practice in Meriden, Connecticut. In his spare time, you can often find Micha reading the latest news about arthritis, lupus, and the healthcare system in news sources such as MedPage Today, Medscape, and Dr. Jack Cush’s RheumNow e-newsletter. He also belongs to the American College of Rheumatology, which is a professional organization that represents rheumatologists and rheumatology health professionals around the world and sits on the Connecticut Rheumatology Association Board of Directors.

Micha Abeles completed his Bachelor of Arts degree at Cornell University in 1967. He then completed his Doctor of Medicine degree at the State University of New York at Buffalo School of Medicine and Biomedical Sciences in 1971.

What Your Healthcare Could Look Like Under Amazon, Berkshire Hathaway and JPMorgan

Earlier this year, Amazon, Berkshire Hathaway, and JPMorgan decided to toss their names into the healthcare ring as they announced they would be forming an independent healthcare company for their employees. The details of this joint venture remain vague, but the aftershocks are still taking the healthcare industry by storm as a new player enters the arena.

Read More

Who’s Liable for the Opioid Crisis?

Earlier in the summer, President Donald Trump declared a national state of emergency regarding the opioid crisis in the United States. The broad class of drugs known as opioids function by acting on the body’s opioid receptors to reduce the sensation of pain. In...
Read More

Biosimilar Usage for Rheumatic Diseases

The treatment of choice for rheumatic diseases has traditionally been the use of biological agents called bio-originators. These agents are derived from microorganisms, animals or humans. The increasing cost of these agents has put effective treatment out of the reach...
Read More